School of Chemistry and Chemical Engineering, Northwestern Polytechnical University, Xi'an, 710072, China.
Division of Chemistry and Biological Chemistry, School of Physical and Mathematical Sciences, Nanyang Technological University, Singapore, 637371, Singapore.
J Nanobiotechnology. 2021 Dec 7;19(1):407. doi: 10.1186/s12951-021-01155-1.
Most activity-based molecular probes are designed to target enzymes that catalyze the breaking of chemical bonds and the conversion of a unimolecular substrate into bimolecular products. However, DNA topoisomerases are a class of enzymes that alter DNA topology without producing any molecular segments during catalysis, which hinders the development of practical methods for diagnosing these key biomarkers in living cells. Here, we established a new strategy for the effective sensing of the expression levels and catalytic activities of topoisomerases in cell-free systems and human cells. Using our newly designed biosensors, we tricked DNA topoisomerases within their catalytic cycles to switch on fluorescence and resume new rounds of catalysis. Considering that human topoisomerases have been widely recognized as biomarkers for multiple cancers and identified as promising targets for several anticancer drugs, we believe that these DNA-based biosensors and our design strategy would greatly benefit the future development of clinical tools for cancer diagnosis and treatment.
大多数基于活性的分子探针被设计用于靶向催化化学键断裂和将单分子底物转化为双分子产物的酶。然而,DNA 拓扑异构酶是一类在催化过程中不产生任何分子片段就能改变 DNA 拓扑结构的酶,这阻碍了开发用于在活细胞中诊断这些关键生物标志物的实用方法。在这里,我们建立了一种在无细胞体系和人细胞中有效检测拓扑异构酶表达水平和催化活性的新策略。使用我们新设计的生物传感器,我们在 DNA 拓扑异构酶的催化循环中设下陷阱,使它们的荧光开启,并恢复新的一轮催化。考虑到人类拓扑异构酶已被广泛认为是多种癌症的生物标志物,并被确定为几种抗癌药物的有前途的靶标,我们相信这些基于 DNA 的生物传感器和我们的设计策略将极大地有益于癌症诊断和治疗的临床工具的未来发展。